Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CL 218872 is a benzodiazepine agonist displaying selectivity for α1 subunit-containing GABAA receptors (Ki values are 130, 1820, 1530, < 10000, 490 and < 10000 nM for α1, α2, α3, α4, α5 and α6-subunit containing receptors respectively). Orally active anxiolytic and anticonvulsant in vivo.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 39.00 | |
25 mg | In stock | $ 84.00 | |
50 mg | In stock | $ 147.00 | |
100 mg | In stock | $ 247.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 32.00 |
Description | CL 218872 is a benzodiazepine agonist displaying selectivity for α1 subunit-containing GABAA receptors (Ki values are 130, 1820, 1530, > 10000, 490 and > 10000 nM for α1, α2, α3, α4, α5 and α6-subunit containing receptors respectively). Orally active anxiolytic and anticonvulsant in vivo. |
Molecular Weight | 278.23 |
Formula | C13H9F3N4 |
CAS No. | 66548-69-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 13.9 mg/mL (50 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CL 218872 66548-69-4 Membrane transporter/Ion channel Neuroscience GABA Receptor Gamma-aminobutyric acid Receptor CL218872 γ-Aminobutyric acid Receptor Inhibitor inhibit CL-218872 inhibitor